Lazarus AH, Ellis J., Semple JW, Mody M., Crow AR, Freedman J.Comparison of platelet immunity in patients with SLE and with ITP. Transfus Sci2000; 22: 19-27.
2.
Kuwana M., Kaburaki J., Okazaki Y., Miyazaki H., Ikeda Y.Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology (Oxford ) 2006; 45: 851-854.
3.
Altintas A., Ozel A., Okur N., et al. Prevalence and clinical significance of elevated antinuclear antibody test in children and adult patients with idiopathic thrombocytopenic purpura. J Thromb Thrombolysis2007; 24: 163-168.
Stasi R., Evangelista ML, Stipa E., Buccisano F., Venditti A., Amadori S.Idiopathic thrombocytopenic purpura: current concepts in pathophysiology and management. Thromb Haemost2008; 99: 4-13.
Lan RY, Ansari AA, Lian ZX, Gershwin MERegulatory T cells: development, function and role in autoimmunity. Autoimmun Rev2005; 4: 351-363.
8.
Sakaguchi S. , Wing K., Miyara M.Regulatory T cells-a brief history and perspective . Eur J Immunol2007; 37(Suppl 1): S116-123.
9.
La Cava A.T-regulatory cells in systemic lupus erythematosus . Lupus2008; 17: 421-425.
10.
Alvarado-Sanchez B., Hernandez-Castro B., Portales-Perez D., et al. Regulatory T cells in patients with systemic lupus erythematosus. J Autoimmun2006; 27: 110-118.
11.
Azab NA, Bassyouni IH, Emad Y., Abd El-Wahab GA, Hamdy G., Mashahit MACD4+CD25+ regulatory T cells (TREG) in systemic lupus erythematosus (SLE) patients: the possible influence of treatment with corticosteroids. Clin Immunol2008; 127: 151-157.
12.
Lin SC, Chen KH, Lin CH, Kuo CC, Ling QD, Chan CHThe quantitative analysis of peripheral blood FOXP3-expressing T cells in systemic lupus erythematosus and rheumatoid arthritis patients. Eur J Clin Invest2007; 37: 987-996.
13.
Kuhn A., Beissert S., Krammer PHCD4(+)CD25 (+) regulatory T cells in human lupus erythematosus. Arch Dermatol Res2009; 301: 71-81.
14.
Cepika AM, Marinic I., Morovic-Vergles J., Soldo-Juresa D., Gagro A.Effect of steroids on the frequency of regulatory T cells and expression of FOXP3 in a patient with systemic lupus erythematosus: a two-year follow-up . Lupus2007; 16: 374-377.
15.
Lee HY, Hong YK, Yun HJ, Kim YM, Kim JR, Yoo WHAltered frequency and migration capacity of CD4+CD25+ regulatory T cells in systemic lupus erythematosus. Rheumatology ( Oxford) 2008; 47: 789-794.
